These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Air line as a possible vector of quarantine cholera]. Fattorini M Minerva Med; 1973 Sep; 64(68):3550-6. PubMed ID: 4798211 [No Abstract] [Full Text] [Related]
3. Cholera vaccination as a tool for cholera control. Barua D Bull Soc Pathol Exot Filiales; 1971; 64(5):652-9. PubMed ID: 5172700 [No Abstract] [Full Text] [Related]
4. [Cholera, pathogenesis, immunology, and protective inoculation]. Günther O Dtsch Med Wochenschr; 1970 Oct; 95(41):2095-7. PubMed ID: 5471802 [No Abstract] [Full Text] [Related]
5. The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. Mosley WH; Woodward WE; Aziz KM; Rahman AS; Chowdhury AK; Ahmed A; Feeley JC J Infect Dis; 1970 May; 121():Suppl 121:1-9. PubMed ID: 4912069 [No Abstract] [Full Text] [Related]
6. [Current problem concerning cholera]. Kima T Dtsch Gesundheitsw; 1971 Jul; 26(30):1390-4. PubMed ID: 5105561 [No Abstract] [Full Text] [Related]
7. Asiatic cholera (with emphasis on pathophysiological effects of the disease). Phillips RA Annu Rev Med; 1968; 19():69-80. PubMed ID: 4871696 [No Abstract] [Full Text] [Related]
9. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera]. María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578 [TBL] [Abstract][Full Text] [Related]
10. Antitoxic immunity in experimental canine cholera. Curlin GT; Subong A; Craig JP; Carpenter CC Trans Assoc Am Physicians; 1968; 81():314-22. PubMed ID: 5721407 [No Abstract] [Full Text] [Related]
11. Summary of recent abstracts. I. Cholera. Cannon DA Trop Dis Bull; 1971 Jan; 68(1):1-16. PubMed ID: 4995927 [No Abstract] [Full Text] [Related]
12. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge. Kundu J; Mazumder R; Srivastava R; Srivastava BS FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752 [TBL] [Abstract][Full Text] [Related]
13. Modern concepts in the treatment of cholera. Rosenbaum BJ Mil Med; 1972 Jan; 137(1):26-8. PubMed ID: 4625076 [No Abstract] [Full Text] [Related]
14. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial. Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiology and prevention of cholera]. Mazzetti G G Mal Infett Parassit; 1971 Apr; 23(4):172-200. PubMed ID: 5115591 [No Abstract] [Full Text] [Related]
18. A new trend in cholera epidemiology. Mukerjee S; Basu S; Bhattacharya P Br Med J; 1965 Oct; 2(5466):837-9. PubMed ID: 5318298 [No Abstract] [Full Text] [Related]
19. [Cholera today]. Madritsch W Schweiz Med Wochenschr; 1967 Apr; 97(17):561-3. PubMed ID: 5587445 [No Abstract] [Full Text] [Related]
20. Immunology of cholera. Finkelstein RA Curr Top Microbiol Immunol; 1975; 69():138-196. PubMed ID: 1098856 [No Abstract] [Full Text] [Related] [Next] [New Search]